Nuwellis (NUWE) FCF Margin Growth (3y) (2016 - 2026)
Nuwellis (NUWE) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 417.00 |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | 20,435.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,435.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,242.00 |
| Jun 30, 2025 | 5,665.00 |
| Mar 31, 2025 | 12,106.00 |
| Dec 31, 2024 | 18,899.00 |
| Sep 30, 2024 | 14,129.00 |
| Jun 30, 2024 | 2,892.00 |
| Mar 31, 2024 | 12,784.00 |
| Dec 31, 2023 | 6,469.00 |
| Sep 30, 2023 | 7,490.00 |
| Jun 30, 2023 | -7,752.00 |
| Mar 31, 2023 | 306.00 |
| Dec 31, 2022 | 16,221.00 |
| Sep 30, 2022 | 14,225.00 |
| Jun 30, 2022 | 6,508.00 |
| Mar 31, 2022 | 15,299.00 |
| Dec 31, 2021 | -7,210.00 |
| Sep 30, 2021 | 598.00 |
| Jun 30, 2021 | 16,348.00 |